Bhekisisa, via Daily Maverick, has produced an informative article discussing significant drug interactions between lenacapavir (LEN) and enzyme-inducing TB treatment such as rifampicin, rifabutin and rifapentine. As we know, HIV and TB exist side-by-side in many communities. Pharmacokinetic modelling has informed advice on how to manage these interactions for now, and ongoing clinical trials will assess the significance of the interaction further. Please call us on 0800 212 506 if you have any further questions regarding LEN drug interactions.

Read more here.